Adult ADHD and substance abuse: Diagnostic and treatment issues

Substance Use and Misuse

Volumn 40, Issue 13-14, 2005, Pages 1955-1981

  Kalbag, Aparna S ^a,c   Levin, Frances R ^a,b,d,e  

^a NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^b Columbia Presbyterian Medical Center ^*  (United States)

^c New York Presbyterian Hospital Columbia University Medical Center   (United States)

^d NYSPI   (United States)

^e NONE   (United States)

Author keywords

Assessment; Attention deficit hyperactivity disorder (ADHD); Dual diagnosis; Substance user populations; Treatment

Indexed keywords

3 METHYL 5 (1 METHYL 2 PYRROLIDINYL)ISOXAZOLE; AMFEBUTAMONE; AMPHETAMINE; ATOMOXETINE; BROMOCRIPTINE; BUSPIRONE; COCAINE; DESIPRAMINE; DEXAMPHETAMINE; GUANFACINE; METHADONE; METHYLPHENIDATE; MODAFINIL; NICOTINE; PEMOLINE; VENLAFAXINE;

ADULT; ATTENTION; ATTENTION DEFICIT DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; COGNITIVE DEFECT; COMORBIDITY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIAGNOSTIC PROCEDURE; DRUG DEPENDENCE; DRUG MEGADOSE; HUMAN; INTELLECTUAL IMPAIRMENT; ONSET AGE; PREVALENCE; PRIORITY JOURNAL; REVIEW; SEDATION; SELF MEDICATION; SIDE EFFECT; SUBSTANCE ABUSE; WEIGHT REDUCTION;

EID: 31544456331     PISSN: 10826084     EISSN: 15322491     Source Type: Journal    
DOI: 10.1080/10826080500294858     Document Type: Review

References (125)

1. Adler, L. A., Kessler, R. C., Spencer, T. (2003). Adult ADHD Self-Report Scale-v1.1 (ASRS-v1.1) Symptom Checklist. New York, NY: World Health Organization. (http://www.med.nyu.edu/Psych/training/adhd.html). Accessed April 8, 2004.
2. Adler, L. A., Resnick, S., Kunz, M., Devinsky, O. (1995). Open-label trial of venlafaxine in adults with attention-deficit disorder. Psychopharmacol Bulletin 31(4):785-758.
3. American Psychiatric Association. (1980). Diagnostic and Statistical Manual of Mental Disorders, version III. Washington, DC: American Psychiatric Press.
4. American Psychiatric Association. (1987). Diagnostic and Statistical Manual of Mental Disorders, version III-R. Washington, DC: American Psychiatric Press.
5. American Psychiatric Association. (1994). Diagnostic and Statistical Manual of Mental Disorders, version IV. Washington, DC: American Psychiatric Press.
6. Armstrong, C. L., Hayes, K. M., Martin, R. (2001). Neurocognitive problems in attention deficit disorder. Alternative concepts and evidence for impairment in inhibition of selective attention. Annals of the New York Academy of Sciences 931:196-215.
7. Aviram, R. B., Rhum, M., Levin, F. R. (2001). Psychotherapy of adults with comorbid attention-deficit/hyperactivity disorder and psychoactive substance use disorder. Journal of Psychotherapy Practice and Research 10(3):179-186.
8. Barkley, R. (1995). Taking Charge of ADHD: The Complete Authoritative Guide for Parents. New York: Guilford Press.
9. Barkley, R. A. (1977). A review of stimulant drug research with hyperactive children. Journal of Child Psychology and Psychiatry 18(2):137-165.
10. Barkley, R. A. (1997). Advancing age, declining ADHD. American Journal of Psychiatry 154(9):1323-1325.
11. Barkley, R. A., Biederman, J. (1997). Toward a broader definition of the age-of-onset criterion for attention-deficit hyperactivity disorder. Journal of American Academy of Child and Adolescent Psychiatry 36(9):1204-1210.
12. Beurrier, C., Malenka, R. C. (2002). Enhanced inhibition of synaptic transmission by dopamine in the nucleus accumbens during behavioral sensitization to cocaine. Journal of Neuroscience 22(14):5817-5822.
13. Biederman, J. (2003). Pharmacotherapy for attention-deficit/hyperactivity disorder (ADHD) decreases the risk for substance abuse: findings from a longitudinal follow-up of youths with and without ADHD. Journal of Clinical Psychiatry 64(Supp.) 11:3-8.
14. Biederman, J. (2004). Impact of comorbidity in adults with attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry 65 (Suppl. 3):3-7.
15. Biederman, J., Faraone, S. V., Spencer, T., Wilens, T., Norman, D., Lapey, K. A., Mick, E., Lehman, B. K., Doyle, A. (1993). Patterns of psychiatric comorbidity, cognition, and psychosocial functioning in adults with attention deficit hyperactivity disorder. American Journal of Psychiatry 150(12):1792-1798.
16. Biederman, J., Mick, E., Faraone, S. V. (2000). Age-dependent decline of symptoms of attention deficit hyperactivity disorder: impact of remission definition and symptom type. American Journal of Psychiatry 157(5):816-818.
17. Biederman, J., Wilens, T., Mick, E., Milberger, S., Spencer, T. J., Faraone, S. V. (1995). Psychoactive substance use disorder in adults with attention deficit hyperactivity disorder (ADHD): effects of ADHD and psychiatric comorbidity. American Journal of Psychiatry 152(11):1652-1658.
18. Biederman, J., Wilens, T., Mick, E., Spencer, T., Faraone, S. V. (1999). Pharmacotherapy of attention-deficit hyperactivity disorder reduces risk for substance use disorder. Pediatrics 104(2):20.
19. Brooks, D. B., Kalbag, A. S., Vosburg, S. K., Evans, S. M., Levin, F. R. Assessment of Cognitive Functioning of Methadone-Maintenance Patients: Impact of Adult ADHD and Current Cocaine Dependence. (Manuscript submitted, 2005).
20. Brown, T. E. (1996). Brown Attention-Deficit Disorder Scales. San Antonio, TX: The Psychological Corporation.
21. Bush, G., Frazier, J. A., Rauch, S. L., Seidman, L. J., Whalen, P. H., Jenike, M. A., Rosen, B. R., Biederman, J. (1999). Anterior cingulated cortex dysfunction in attention-deficit hyperactivity disorder revealed by fMRI and the counting stroop. Biological Psychiatry 45(12):1542-1552.
22. Carroll, K. M., Rounsaville, B. J. (1993). History and significance of childhood attention deficit disorder in treatment-seeking cocaine abusers. Comprehensive Psychiatry 34(2):75-82.
23. Carter, C. S., Krener, P., Chaderjian, M., Northcutt, C., Wolfe, V. (1995). Asymmetrical visual-spatial attentional performance in ADHD: evidence for a right hemispheric deficit. Biological Psychiatry 37(11):789-797.
24. Cavanagh, R., Clifford, J. S., Gregory, W. L. (1989). The use of bromocriptine for the treatment of attention deficit disorder in two chemically dependent patients. Journal of Psychoactive Drugs 21(2):217-220.
25. Clure, C., Brady, K. T., Saladin, M. E., Johnson, D., Waid, R., Rittenbury, M. (1999). Attention-deficit/hyperactivity disorder and substance use: symptom pattern and drug choice. American Journal of Drug and Alcohol Abuse 25(3):441-448.
26. Cocores, J. A., Davies, R. K., Mueller, P. S., Gold, M. S. (1987). Cocaine abuse and adult attention deficit disorder. Journal of Clinical Psychiatry 48(9):376-377.
27. Conners, C. K., Erhart, D., Sparrow E. (1999). Conners' Adult ADHD Rating Scales, Technical Manual. New York: Multi-Health Systems.
28. Cook, E. H. Jr., Stein, M. A., Krasowski, M. D., Cox, N. J., Olkon, D. M., Kieffer, J. E., Leventhal, B. L. (1995). Association of attention-deficit disorder and the dopamine transporter gene. American Journal of Human Genetics 56(4):993-998.
29. Dansereau, D. F., Joe, G. W., Simpson, D. D. (1995). Attentional difficulties and the effectiveness of a visual representation strategy for counseling drug-addicted clients. International Journal of the Addictions 30(4):371-86.
30. Dupaul, G., Power, T., Anastopoulos, A., Reid, R. (1998). ADHD Rating Scale, IV: Checklists, Norms and Clinical Interpretation. New York: Guilford Press.
31. Epstein, J. N., Johnson, D. E., Conners, C. K. (2001). Conners' Adult ADHD Diagnostic Interview for DSM-IV (CAADID). North Tonawanda, NY: Multi-Health Systems Inc.
32. Ernst, M., Zametkin, A. J., Phillips, R. L., Cohen, R. M. (1998). Age-related changes in brain glucose metabolism in adults with attention-deficit hyperactivity disorder and control subjects. Journal of Neuropsychiatry and Clinical Neurosciences 10(2):168-177.
33. Eyre, S. L., Rounsaville, B. J., Kleber, H. D. (1982). History of childhood hyperactivity in a clinic population of opiate addicts. Journal of Nervous and Mental Disease 170(9):522-529.
34. Faraone, S. V., Biederman, J., Spencer, T., Wilens, T., Seidman, L. J., Mick, E., Doyle, A. E. (2000). Attention-deficit/ hyperactivity disorder in adults: an overview. Biological Psychiatry 48(1):9-20.
35. Faraone, S. V., Biederman, J., Weiffenbach, B., Keith, T., Chu, M. P., Weaver, A., Spencer, T. J., Wilens, T. E., Frazier, J., Cleves, M., Sakai, J. (1999). Dopamine D4 gene 7-repeat allele and attention deficit hyperactivity disorder. American Journal of Psychiatry 156(5):768-770.
36. Findling, R. L., Schwartz, M. A., Flannery, D. J., Manos, M. J. (1996). Venlafaxine in adults with attention-deficit hyperactivity disorder an open clinical trial. Journal of Clinical Psychiatry 57(5):184-189.
37. Flory, K., Milich, R., Lynam, D. R., Leukefeld, C., Clayton, R. (2003). Relation between childhood disruptive behavior disorders and substance use and dependence symptoms in young adulthood: individuals with symptoms of attention-deficit hyperactivity disorder and conduct disorder are uniquely at risk. Psychology of Addictive Behaviors 17(2):151-158.
38. Gill, M., Daly, G., Heron, S., Hawi, Z., Fitzgerald, M. (1997). Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism. Molecular Psychiatry 2(4):311-313.
39. Gittleman, R., Mannuzza, S., Shenker, R., Bonagura, N. (1985). Hyperactive boys almost grown up. I. Psychiatric status. Archives of General Psychiatry 42(10):937-947.
40. Greenfield, B., Hechtman, L., Weiss, G. (1988). Two subgroups of hyperactives as adults: correlations of outcome. Canadian Journal of Psychiatry 33(6):505-508.
41. Greenhill, L. L. (1992). Pharmacologic treatment of attention deficit hyperactivity disorder. Psychiatric Clinics of North America 15(1):1-27.
42. Grodzinsky, G. M., Barkley, R. A. (1999). Predictive power of frontal lobe tests in the diagnosis of attention-deficit hyperactivity disorder. Archives of Clinical Neuropsychology 13(1):12-21.
43. Hechtman, L., Greenfield, B. (2003). Long-term use of stimulants in children with attention deficit hyperactivity disorder: safety, efficacy, and long-term outcome. Pediatric Drugs 5(12):787-794.
44. Hedges, D., Reimherr, F. W., Rogers, A., Strong, R., Wender, P. H. (1995). An open trial of venlafaxine in adult patients with attention- deficit hyperactivity disorder. Psychopharmacol Bulletin 31(4):779-783.
45. Hesslinger, B., Tebartz van Elst, L., Nyberg, E., Dykierek, P., Richter, H., Berner, M., Ebert, D. (2002). Psychotherapy of Attention deficit hyperactivity disorder in adults: a pilot study using a structured skills training program. European Archives of Psychiatry and Clinical Neuroscience 252(4):177-184.
46. Hien, D., Matzner, F., First, M., Spitzer, R., Williams, J., Gibbon, M. (2001). The Structured Clinical Interview for DSM-IV, Childhood version (KID-SCID). Unpublished instrument, 2001 (revised).
47. Higgins, S. T. Budney, A. J. Bickel, W. K. Foerg, F. E. Donham, R., Badger, G. J. (1994). Incentives improve outcome in outpatient behavioral treatment for cocaine dependence. Archives of General Psychiatry 51(7):568-576.
48. Hill, J. C., Schoener, E. P. (1996). Age-dependent decline of attention deficit hyperactivity disorder. American Journal of Psychiatry 153(9):1143-1146.
49. Hoffman, B. B., Lefkowitz, R. J. (1996). Catecholamines, sympathomimetic drugs and adrenergic receptor agonists. In Jardman, J. G., et al., eds. Goodman & Gilman's The Pharmacological Basis of Therapeutics. New York: McGraw-Hill, pp. 199-263.
50. Horrigan, J. P., Barnhill, L. J. (2000). Low-dose amphetamine salts and adult attention-deficit/hyperactivity disorder. Journal of Clinical Psychiatry 61(6):414-417.
51. Kalbag, A. S., Brooks, D. J., Evans, S. M., Nunes, E. V., Levin, F. R. The relationship between the specific and non-specific ADHD symptoms and addiction severity in a methadone-maintained sample of adults with ADHD. Manuscript in preparation.
52. Kessler, R.C., McGonagle, K. A., Shao, S., Nelson, C. B., Hughes, M., Eshleman, S., Wittchen, H. U., Kendler, K. S. (1994). Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey. Archives of General Psychiatry 51(1):8-19.
53. Khantzian, E. J. (1983). An extreme case of cocaine dependence and marked improvement with methylphenidate treatment. American Journal of Psychiatry 140(6):784-785.
54. Khantzian, E. J., Gawin, F., Kleber, H. D., Riordan, C. E. (1984). Methylphenidate (Ritalin) treatment of cocaine dependence a preliminary report. Journal of Substance Abuse Treatment 1(2):107-112.
55. King, V. L., Brooner, R. K., Kidorf, M. S., Stoller, K. B., Mirsky, A. F. (1999). Attention deficit hyperactivity disorder and treatment outcome in opioid abusers entering treatment. Journal of Nervous and Mental Disease 187(8):487-495.
56. Kuperman, S., Perry, P., Gaffney, G., Lund, B., Bever-Stille, K., Arndt, S., Holman, T. L., Moser, D., Paulsen, J. (2001). Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults. Annals of Clinical Psychiatry 13(3):129-134.
57. LaHoste, G. J., Swanson, J. M., Wigal, S. B., Glabe, C., Wigal, T., King, N., Kennedy, J. L. (1996). Dopamine D4 receptor gene polymorphism is associated with attention deficit hyperactivity disorder. Molecular Psychiatry 1(2):121-124.
58. Lambert, N. M., Hartsough, C. S. (1998). Prospective study of tobacco smoking and substance dependencies among samples of ADHD and non-ADHD participants. Journal of Learning Disabilities 31(6):533-544.
59. Levin, F. R., Evans, S. M., Kleber, H. D. (1998). Prevalence of adult attention-deficit hyperactivity disorder among cocaine abusers seeking treatment. Drug and Alcohol Dependence 52(1):15-25.
60. Levin, F. R., Evans, S. M., McDowell, D. M., Brooks, D. J., Nunes, E. (2002). Bupropion treatment for cocaine and adult attention-deficit hyperactivity disorder. Journal of Addictive Disorders 21(2):1-16.
61. Levin, F. R., Evans, S. M., McDowell, D. M., Kleber, H. D. (1998). Methylphenidate treatment for cocaine abusers with adult attention-deficit/ hyperactivity disorder: a pilot study. Journal of Clinical Psychiatry 59(6):300-305.
62. Levin, F. R., Evans, S. M., Vosburg, S. K., Horton, T., Brooks, D., Ng, J. (2004). Impact of attention deficit hyperactivity disorder and other psychopathology on treatment retention among cocaine abusers in a therapeutic community. Addictive Behaviors 29(9):1875-1882.
63. Levin, F. R., Kleber, H. D. (1995). Attention-deficit hyperactivity disorder and substance abuse: relationship and implications for treatment. Harvard Review of Psychiatry 2(5):246-258.
64. Linehan, M. M., Armstrong, H. E., Suarez, A., Allmon, D., Heard, H. L. (1991). Cognitive-behavioral treatment of chronically parasuicidal borderline patients. Archives of General Psychiatry 48(12):1060-1064.
65. Linehan, M. M., Schmidt, H. 3rd, Dimeff, L. A., Craft, J. C., Kanter, J., Comtois, K. A. (1999). Dialectical behavior therapy of patients with borderline personality disorder and drug-dependence. American Journal on Addictions 8(4):279-292.
66. Lovejoy, D. W., Ball, J. D., Keats, M., Stutts, M. L., Spain, E. H., Janda, L., Janusz, J. (1999). Neuropsychological performance of adults with attention-deficit hyperactivity disorder (ADHD): diagnostic classification estimates for measures of frontal lobe/executive functioning. J Int Neuropsychol Soc 5(3):222-233.
67. Lowe, N., Kirley, A., Hawi, Z., Sham, P., Wickham, H., Kratochvil, C. J., Smith, S. D., Lee, S. Y., Levy, F., Kent, L., Middle, F., Rohde, L. A., Roman, T., Tahir, E., Yazgan, Y., Asherson, P., Mill, J., Thapar, A., Payton, A., Todd, R. D., Stephens, T., Ebstein, R. P., Manor, I., Barr, C. L., Wiggs, K. G., Sinke, R. J., Buitelaar, J. K., Smalley, S. L., Nelson, S. F., Biederman, J., Faraone, S. V., Gill, M. (2004). Joint analysis of the DRD5 marker concludes associations with attention-deficit hyperactivity disorder confined to the predominantly inattentive and combined subtypes. American Journal of Human Genetics 74(2):348-356.
68. Mannuzza, S., Klein, R. G. (2000). Long-term prognosis in attention-deficit hyperactivity disorder. Child and Adolescent Pediatric Clinics of North America 9(3):711-726.
69. Mannuzza, S., Klein, R. G., Bessler, A., Malloy, P., Hynes, M. E. (1997). Educational and occupational outcome of hyperactive boys grown up. Journal of American Academy of Child Adolescent Psychiatry 36(9):1222-1227.
70. Mannuzza, S., Klein, R. G., Bessler, A., Malloy, P., LaPadula, M. (1993). Adult outcome of hyperactive boys. Educational achievement, occupational rank, and psychiatric status. Archives of General Psychiatry 50(7):565-576.
71. Mannuzza, S., Klein, R. G., Bessler, A., Malloy, P., LaPadula, M. (1998). Adult psychiatric status of hyperactive boys grown up. American Journal of Psychiatry 155(4):493-498.
72. Mannuzza, S., Klein, R. G., Bonagura, N., Malloy, P., Giampino, T. L., Addalli, K. A. (1991). Hyperactive boys almost grown up. V. Replication of psychiatric status. Archives of General Psychiatry 48(1):77-83.
73. Mannuzza, S., Klein, R. G., Moulton, J. L. (2003). Does stimulant treatment place children at risk for adult substance abuse? A controlled, prospective follow-up study. Journal of Child and Adolescent Psychopharmacology 13(3):273-282.
74. Mannuzza, S., Klein, R. G., Moulton, J. L. (2003). Persistence of attention-deficit/hyperactivity disorder into adulthood: what have we learned from the prospective follow-up studies? Journal of Attention Disorders 7(2):93-100.
75. Mattes, J. A., Boswell, L., Oliver, H. (1984). Methylphenidate effects on symptoms of attention deficit disorder in adults. Archives of General Psychiatry 41(11):1059-1063.
76. Michelson, D., Adler, L., Spencer, T., Reimherr, F. W., West, S. A., Allen, A. J., Kelsey, D., Wernicke, J., Dietrich, A., Milton, D. (2003). Atomoxetine in adults with ADHD: two randomized, placebo-controlled studies. Biological Psychiatry 53:112-120.
77. Milberger, S., Biederman, J., Faraone, S. V., Wilens, T., Chu, M. P. (1997). Associations between ADHD and psychoactive substance use disorders. Findings from a longitudinal study of high-risk siblings of ADHD children. American Journal on Addictions 6(4):318-329.
78. MTA cooperative group. (1999). A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. The MTA cooperative group. Multimodal treatment study of children with ADHD. Archives of General Psychiatry 56(12):1073-1086.
79. Murphy, K. R., Barkley, R. A., Bush, T. (2002). Young adults with attention-deficit hyperactivity disorder: subtype differences in comorbidity, educational and clinical history. Journal of Nervous and Mental Disease 190(3):147-157.
80. Niederhofer, H. (2003). An open trial of busiprone in the treatment of attention-deficit disorder. Human Psychopharmacology 18(6):489-492.
81. Orvaschel, H. (1985). Psychiatric interviews suitable for use in research with children and adolescents. Psychopharmacol Bulletin 21(4):737-745.
82. Paternite, C. E., Loney, J., Salisbury, H., Whaley, M. A. (1999). Childhood inattention-overactivity, aggression, and stimulant medication history as predictors of young adult outcomes. Journal of Child and Adolescent Psychopharmacology 9(3):169-184.
83. Paterson, R., Douglas, C., Hallmayer, J., Hagan, M., Krupenia, Z. (1999). A randomized, double-blind, placebo-controlled trial of dexamphetamine in adults with attention deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry 33(4):494-502.
84. Pelham, W. E., Sams, S. E. (1992). Behavior modification. In G Weiss, ed. Child and Adolescent Psychiatric Clinics of North America. Philadelphia, PA: W. B. Saunders, pp. 505-518.
85. Pomeraleau, O. F., Downey, K. K., Stelson, F. W., Pomeraleau, C. S. (1995). Cigarette smoking in adult patients diagnosed with attention deficit hyperactivity disorder. Journal of Substance Abuse 7(3):373-378.
86. Regier, D.A., Farmer, M. E., Rae, D. S., Locke, B. Z., Keith, S. J., Judd, L. L., Goodwin, F. K. (1990). Comorbidity of mental disorders with alcohol and other drug abuse. Results form the Epidemiologic Catchment Area (ECA) Study. Journal of American Medical Association 264(19):2511-2518.
87. Rounsaville, B. J., Anton, S. F., Carroll, K., Budde, D., Prusoff, B. A., Gawin, F. (1991). Psychiatric diagnosis of treatment-seeking cocaine abusers. Archives of General Psychiatry 48(1):43-51.
88. Rubia, K., Overmeyer, S., Taylor, E., Brammer, M., Williams, S. C., Simons, A., Bullmore, E. T. (1999). Hyprofrontality in attention-deficit hyperactivity disorder during higher-order motor control, a study with functional MRI. American Journal of Psychiatry 156(6):891-896.
89. Rugino, T. A., Samsock, T. C. (2003). Modafinil in children with attention-deficit hyperactivity disorder. Pediatric Neurology 29(2):136-142.
90. Schubiner, H., Saules, K. K., Arfken, C. L., Johanson, C. E., Schuster, C. R., Lockhart, N., Edwards, A., Donlin, J., Philgren, E. (2000). Double-blind placebo-controlled trial of methylphenidate in the treatment of adult ADHD patients with comorbid cocaine dependence. Experimental and Clinical Psychopharmacology 10(3):286-294.
91. Schweitzer, J. B., Faber, T. L., Grafton, S. T., Tune, L. E., Hoffman, J. M., Kilts, C. D. (2000). Alterations in the functional anatomy of working memory in adult attention deficit hyperactivity disorder. American Journal of Psychiatry 157(2):278-280.
92. Seidman, L. J., Biederman, J., Weber, W., Hatch, M., Faraone, S. V. (1998). Neuropsychological function in adults with attention-deficit hyperactivity disorder. Biological Psychiatry 44(4):260-268.
93. Sohlberg, M. M., Mateer, C. A. (2001). Improving attention and managing attentional problems. Adapting rehabilitation techniques to adults with ADD. Annals of the New York Academy of Sciences 931:359-375.
94. Somoza, E., Bridge, P., Winhusen, T., Rotrosen, J., Vanderburg, D., Harrer, J., Mezinskis, J., Montgomery, A., Leiderman, D., Locastro, J., Wulsin, L., Barrett, J. (2000). An open-label pilot study of methylphenidate in the treatment of cocaine-dependence patients with attention deficit hyperactivity disorder. Drug and Alcohol Dependence 60(1):S208.
95. Spencer, T., Biederman, J., Wilens, T., Faraone, S., Prince, J., Gerard, K., Doyle, R., Parekh, A., Kagan, J., Bearman, S. K. (2001). Efficacy of a mixed amphetamine salts compound in adults with attention-deficit hyperactivity disorder. Archives of General Psychiatry 58(8):775-782.
96. Spencer, T., Biederman, J., Wilens, T., Prince, J., Hatch, M., Jones, J., Harding, M., Faraone, S. V., Seidman, L. (1998). Effectiveness and tolerability of tomoxetine in adults with attention-deficit hyperactivity disorder. American Journal of Psychiatry 155(5):693-695.
97. Spencer, T., Wilens, T., Biederman, J., Faraone, S. V., Ablon, J. S., Lapey, K. (1995). A double-blind, crossover comparison of methylphenidate and placebo in adults with childhood-onset attention-deficit hyperactivity disorder. Archives of General Psychiatry 52(6):434-443.
98. Stevenson, C. S., Whitmont, S., Bornholt, L., Livesey, D., Stevenson, R. J. (2002). A cognitive remediation programme for adults with attention-deficit hyperactivity disorder. Australian and New Zealand Journal of Psychiatry 36(5):610-616.
99. Sullivan, M., Levin, F. R. (2001). Attention deficit/hyperactivity disorder and substance abuse: diagnostic and therapeutic considerations. In Adult Attention Deficit Disorder: Brain Mechanisms and Life Outcomes. J. Wasserstein, Wolf, L. E., Lefever, F. F., (eds). Annals of the New York Academy of Sciences 931:251-270.
100. Szatmari, P. (1992). The epidemiology of attention-deficit hyperactivity disorder. In G. Weiss, guest ed. Child and Adolescent Psychiatric Clinics of North America pp. 361-384.
101. Taylor, F. B., Russo, J. (2000). Efficacy of modafinil compared to dextroamphetamine for the treatment of attention deficit hyperactivity disorder in adults. Journal of Child and Adolescent Psychopharmacology 10(4):311-320.78.
102. Taylor, F., Russo, J. (2001). Comparing guanfacine and dextroamphetamine for the treatment of adult attention-deficit/hyperactivity disorder. Journal of Psychopharmacology 21(2):223-228.
103. Thompson, L. L., Riggs, P. D., Mikulich, S. K., Crowley, T. J. (1996). Contribution and ADHD symptoms to substance problems and delinquency conduct-disordered adolescents. Journal of Abnormal Child Psychology 24(3):325-347.
104. Vaidya, C. J., Austin, G., Kirkorian, G., Ridlehuber, H. W., Desmond, J. E., Glover, G. H., Gabrieli, J. D. (1998). Selective effects of methylphenidate in attention-deficit hyperactivity disorder: a functional magnetic resonance study. Proceeding of the National Academy of Sciences of the United States of America 95(24):14494-14499.
105. Ward, M. F., Wender, P. H., Reimherr, F. W. (1993). The Wender Utah Rating Scale: an aid in the retrospective diagnosis of childhood attention deficit hyperactivity disorder. American Journal of Psychiatry 150(6):885-890.
106. Weinstein, C. S. (1994). Cognitive remediation strategies: an adjunct to the psychotherapy of adults with attention-deficit hyperactivity disorder. Journal of Psychotherapy Practice and Research, 3:44-57.
107. Weiss, G., Hechtman, L. T. (1986). Adult hyperactive subjects' view of their treatment in childhood and adolescence. In Hyperactive Children Grown Up: Empirical Finding and Theoretical Considerations. Guilford. New York: pp. 293-300.
108. Weiss, M., Hechtman, L. T., Weiss, G. (1999). ADHD in Adulthood: A Guide to Current Theory, Diagnosis, and Treatment. Baltimore, MD: The Johns Hopkins University Press.
109. Wender, P. H. (1995). Attention-Deficit Hyperactivity Disorder in Adults. New York: Oxford University Press.
110. Wender, P. H., Ward, M. F., Reimherr, F. W., Marchant, B. K. (2000). ADHD in adults. Journal of American Academy of Child Adolescent Psychiatry 39(5):543.
111. West, S. L., Mulsow, M., Arrendondo, R. (2003). Factor analysis of attention deficit scales for adults (ADSA) in a clinical sample of outpatient substance abusers. American Journal on Addictions 12(2)159-165.
112. Wilens, T. E., Biederman, J., Abrantes, A. M., Spencer, T. J. (1997). Clinical characteristics of psychiatrically referred adolescent outpatients with substance use disorder. Journal of American Academy of Child Adolescent Psychiatry 36:941-947.
113. Wilens, T. E., Biederman, J., Prince, J., Spencer, T. J., Faraone, S. V., Warburton, R., Schleifer, D., Harding, M., Linehan, C., Geller, D. (1996). Six-week, double-blind, placebo-controlled study of desipramine for adult attention deficit hyperactivity disorder. American Journal of Psychiatry 153(9):1147-1153.
114. Wilens, T. E., Biederman, J., Spencer, T. J. (1995). Venlafaxine for adult ADHD. American Journal of Psychiatry 152(7):1099-1100.
115. Wilens, T. E., Biederman, J., Spencer, T. J., Bostic, J., Prince, J., Monuteaux, M. C., Soriano, J., Fine, C., Abrams, A., Rater, M., Polisner, D. (1999). A pilot controlled clinical trial of ABT-418, a cholinergic agonist in the treatment of adults with attention deficit hyperactivity disorder. American Journal of Psychiatry 156(12):1931-1937.
116. Wilens, T. E., Biederman, J., Spencer, T. J., Frazier, J., Prince, J., Bostic, J., Rater, M., Soriano, J., Hatch, M., Sienna, M., Millstein, R. B., Abrantes, A. (1999). Controlled trial of high doses of pemoline for adults with attention deficit/hyperactivity disorder. Journal of Clinical Psychopharmacology 19(3):257-264.
117. Wilens, T. E., Biederman, J., Spencer, T. J., Prince, J. (1995). Pharmacotherapy of adult attention deficit-hyperactivity disorder: a review. Journal of Clinical Psychopharmacology 15(4):270-279.
118. Wilens, T. E., Faraone, S. V., Biederman, J., Gunawardene, S. (2003). Does stimulant therapy of attention-deficit/hyperactivity disorder beget later substance abuse? A meta-analytic review of the literature. Pediatrics 111(1):179-185.
119. Wilens, T. E., Spencer, T. J., Biederman, J., Girard, K., Doyle, R., Prince, J., Polsiner, D., Sohlkhah, R., Comeau, S., Monuteaux, M. C., Parekh, A. (2001). A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults. American Journal of Psychiatry 158(2):282-288.
120. Wise, B. K., Cuffe, S. P., Fischer, T. (2001). Dual Diagnosis and successful participation of adolescents in substance abuse treatment. Journal of Substance Abuse Treatment 1:161-165.
121. Wise, R. A. (1998). Drug-activation of brain reward pathways. Drug and Alcohol Dependence 51(1-2):13-22.
122. Wonnacott, S., Irons, J., Rapier, C., Thorne, B., Lunt, G. G. (1989). Presynaptic modulation of transmitter release by nicotinic receptors. Progress in Brain Research 79:157-163.
123. Wood, D., Wender, P. H., Reimherr, F. W. (1983). The prevalence of attention deficit disorder, residual type, or minimal brain dysfunction, in a population of male alcoholic patients. American Journal of Psychiatry 140(1):95-98.
124. Zametkin, A. J., Liebenauer, L. L., Fitzgerald, G. A., King, A. C., Minkunas, D. V., Herscovitch, P., Yamada, E. M., Cohen, R. M. (1993). Brain metabolism in teenagers with attention-deficit hyperactivity disorder. Archives of General Psychiatry 50(5):333-340.
125. Zametkin, A. J., Nordahl, T. E., Gross, M., King, A. C., Semple, W. E., Rumsey, J., Hamburger, S., Cohen, R. M. (1990). Cerebral glucose metabolism in adults with hyperactivity for childhood onset. New England Journal of Medicine 323(20):1361-1366.